Faculty, Staff and Student Publications
Publication Date
6-1-2023
Journal
Journal of Controlled Release
Abstract
Several implantable long-acting (LA) delivery systems have been developed for sustained subcutaneous administration of tenofovir alafenamide (TAF), a potent and effective nucleotide reverse transcriptase inhibitor used for HIV pre-exposure prophylaxis (PrEP). LA platforms aim to address the lack of adherence to oral regimens, which has impaired PrEP efficacy. Despite extensive investigations in this field, tissue response to sustained subcutaneous TAF delivery remains to be elucidated as contrasting preclinical results have been reported in the literature. To this end, here we studied the local foreign body response (FBR) to sustained subdermal delivery of three forms of TAF, namely TAF free base (TAF
Keywords
Rats, Animals, Tenofovir, Anti-HIV Agents, HIV Infections, Macaca mulatta, Rats, Sprague-Dawley, Adenine, Alanine